Investor appetite for AI-enabled drug discovery growing in China: Insilico founder

Investor appetite for AI-enabled drug discovery growing in China: Insilico founder

Alex Zhavoronkov, founder and CEO of Hong Kong-based Insilico Medicine

Eudora Wang

26 March, 2021

AI drug discoveryAlex ZhavoronkovBaiduInsilico MedicineQiming Venture Partners

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.